Genex Pharmaceutical, Inc. engages in the development and production of Reconstituted Bone Xenograft, which is a medical device that accelerates bone healing. The company is headquartered in Tianjin, Tianjin and currently employs 86 full-time employees. The company went IPO on 2006-05-23. The Company’s main business is engaged in producing and distributing Reconstituted Bone Xenograft (RBX). The RBX is used as a medical device that accelerates bone healing. The firm distributes its medical devices to hospitals as well as other medical device customers that are not hospitals. The firm mainly conducts its business in the domestic market.
Follow-Up Questions
Quel est le ratio P/E de Genex Pharmaceutical Inc (GENX) ?
Le ratio P/E de Genex Pharmaceutical Inc est de 0.0009
Qui est le CEO de Genex Pharmaceutical Inc ?
Song Fuzhi est le Chairman of the Board de Genex Pharmaceutical Inc, il a rejoint l'entreprise depuis 2004.
Quelle est la performance du prix de l'action GENX ?
Le prix actuel de GENX est de $0, il a decreased de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Genex Pharmaceutical Inc ?
Genex Pharmaceutical Inc appartient à l'industrie Health Care et le secteur est Health Care
Quel est la capitalisation boursière de Genex Pharmaceutical Inc ?
La capitalisation boursière actuelle de Genex Pharmaceutical Inc est de $0
